This site is intended for healthcare professionals only
LoginRegister
NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP UniformityNPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details
Lupins Indore Plant Gets 6 Observations After USFDA InspectionLupin's generic drug to treat ADHD symptoms gets USFDA approval
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsUSFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility
Novo Nordisks Wegovy Gets UK Nod for Higher 7.2 mg Weekly Dose in Obesity TreatmentNovo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients
Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus DealEli Lilly's Experimental Drug Muvalaplin Lowers Inherited Cholesterol by Up to 86 percent
Lupin unveils Risperidone Long Acting Injectable in USLupin launches generic equivalent of Bumex Injection in US
Pharm D Graduates Now Eligible for Drug Inspector Recruitment, Says MPSCTN Health to close registration, choice filling for Pharm D Counselling Tomorrow, check seat matrix
USFDA approves AbbVie giant cell arteritis drug Rinvoq in adultsAbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer
Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in bloodIndian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult...
Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide allianceRatio enters license, collaboration agreement with Novartis for SSTR2-targeting Radiotherapeutic...
X